Solution for injections Tornid the RG is shown for treatment of the hypostases and/or exudates caused by heart failure if intravenous use of medicine, for example, in case of a fluid lungs owing to an acute heart failure is necessary.

Structure

Active ingredient: torasemid.

1 ml of solution for injections the torasemida in terms of 100% contains dry matter - 5 mg.

Excipients: polyethyleneglycol (macrogoal) 400, trometamol, sodium hydroxide, water for injections.

Contraindication

• Hypersensitivity to active ingredient, medicaments of sulphonylurea and to any of medicament excipients.
• Renal failure with an anury.
• Hepatic coma or prekoma.
• Arterial hypotension.
• Hypovolemia.
• Hyponatremia.
• Hypopotassemia.
• Acute disorder of urination, for example owing to a prostatauxe. Feeding period breast.

Treatment to begin with

with reception of a single dose 2 ml TORNID of the RG that is equivalent to 10 mg of a torasemid a day. If the effect is insufficient, then it is possible to increase a single dose to 4 ml of medicament TORNID RG that is equivalent to 20 mg of a torasemid. If the effect also in this case is insufficiently, it is possible to perform short-term (within no more than 3 days) therapy with introduction of a daily dose of 8 ml of medicament TORNID RG that is equivalent to 40 mg of a torasemid.

Feature

Pregnant women

Reliable data about influence of a torasemid on pregnant women are absent.

Safety and efficiency of use of RG TORNID medicine aged up to 18 years are not established to children and teenagers by

.

Drivers

Even at use in the recommended doses torasemid can have negative effect on speed of response at control of motor transport or other mechanisms.

intoxication Symptoms

Typical symptomatology is unknown to

. The overdose can cause a severe diuresis, including risk of excessive loss of water and electrolytes, drowsiness, a syndrome of confusion of consciousness, symptomatic hypotension, circulator collapse and disturbances from digestive system.

overdose Treatment. Specific antidote is unknown. Symptoms of intoxication disappear, usually at reduction of a dose and cancellation of medicine and at the corresponding substitution of liquid and electrolytes (it is necessary to carry out control). Torasemid is not brought from blood by means of a hemodialysis.

Treatment in case of a hypovolemia: substitution of volume of liquid.

Treatment in case of a hypopotassemia: prescribing of medicaments of potassium.

Treatment in case of circulator collapse: to translate the patient in a prone position of the patient and if necessary to appoint symptomatic therapy.

by

Acute anaphylaxis (immediate measures)

At the first emergence of skin reactions (such as, for example, small tortoiseshell or erubescence), the excited condition of the patient, a headache, the increased perspiration, nausea, cyanosis it is necessary to carry out catheterization of a vein of the patient to put in horizontal position, to provide free intake of air, to appoint oxygen. In case of need further to apply also means of intensive care (including administration of epinephrine, GKS and substitution of volume of the circulating blood).

Side effects

from nervous system. Often: a headache, dizziness (especially in an initiation of treatment). Sometimes: paresthesias. Very seldom faints, cerebral ischemia, confusion of consciousness.

from organs of sight. Very seldom: disorder of vision.

from organs of hearing and a labyrinth. Very seldom a ring in ears, a hearing loss.

from a cardiovascular system. Very seldom myocardium ischemia, arrhythmia, stenocardia, acute myocardial infarction.

from the vascular system. Very seldom tromboembolic episodes, arterial hypotension and also circulatory disturbances in heart and disturbances of the central blood circulation.

from digestive tract. Often disturbances from digestive tract (for example, lack of appetite, a stomach ache, nausea, vomiting, a diarrhea, obstipation), especially in an initiation of treatment. Sometimes: xerostomia. Very seldom pancreatitis.

from a liver and biliary tract. Often: increase in concentration of some liver enzymes (gamma glutamiltranspeptidazy) in blood.

from skin and hypodermic fatty tissue. Very seldom allergic reactions (for example, itching, rash, photosensitization), skin reactions.

from a musculoskeletal system and connective tissue. Often spasms of muscles (especially in an initiation of treatment).

from kidneys and urinary tract. Sometimes: at urination disturbance (for example, in a prostatauxe) the increased formation of urine can be followed by an ischuria and a cystectasia.

Interaction

Torasemid, especially in high doses, can strengthen from and nephrotoxic action of aminoglikozidny antibiotics, for example Kanamycinum, gentamycin, Tobramycinum and tsitostatik - active derivatives of platinum and also nephrotoxic effect of cephalosporins.

to Store

in original packing at a temperature not above 25 °C. To store out of children's reach.

Expiration date: 2 years.